SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 216.43 |
Enterprise Value ($M) | n/a |
Book Value ($M) | 257.82 |
Book Value / Share | 2.73 |
Price / Book | n/a |
NCAV ($M) | 119.10 |
NCAV / Share | 1.26 |
Price / NCAV | n/a |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.87 |
Return on Assets (ROA) | -0.42 |
Return on Equity (ROE) | -0.45 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 2.11 |
Current Ratio | 4.28 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 160.29 |
Assets | 299.01 |
Liabilities | 41.19 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 161.64 |
Operating Income | -52.86 |
Net Income | -248.60 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -38.78 |
Cash from Investing | 4.94 |
Cash from Financing | -0.82 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D/A | BT DE Investments Inc. | 29.90 | 84.55 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
2,995,284 | 8,446,817 | 35.46 | |
429,144 | 428,874 | 100.06 | |
309,775 | 309,477 | 100.10 | |
588,257 | 2,912,283 | 20.20 | |
(click for more detail) |
Similar Companies | |
---|---|
NUVL – Nuvalent, Inc. | NVAX – Novavax, Inc. |
NXTC – NextCure, Inc. | OLMA – Olema Pharmaceuticals, Inc. |
OMGA – Omega Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io